New partnership to advance novel airway-delivered gene therapy for treating pulmonary hypertension – News-Medical.net
News-Medical.net |
New partnership to advance novel airway-delivered gene therapy for treating pulmonary hypertension
News-Medical.net Mount Sinai has partnered with Theragene Pharmaceuticals, Inc. to advance a novel airway-delivered gene therapy for treating pulmonary hypertension (PH), a form of high blood pressure in blood vessels in the lungs that is linked to heart failure. |
